Evidence map›Paper›PMID 35484171›Full record

ArticleScientific reports2022

Circulating microRNA profiling is altered in the acute respiratory distress syndrome related to SARS-CoV-2 infection.

Natalia Garcia-Giralt, Juan Du, Judith Marin-Corral, Marta Bódalo-Torruella, Fabiola Blasco-Hernando, Rosana Muñoz-Bermúdez, Miquel Clarós, Lara Nonell, Julia Perera-Bel, Marta Fernandez-González and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Long COVID: Molecular Mechanisms and Detection Techniques.International journal of molecular sciences · 2023
    Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Natalia Garcia-GiraltCentro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), IMIM (Hospital del Mar Research Institute), Barcelona, Spain. ngarcia@imim.es.ORCID 0000-0001-6507-0147
Juan DuCentro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), IMIM (Hospital del Mar Research Institute), Barcelona, Spain.
Judith Marin-CorralCritical Care Department, Hospital del Mar, Barcelona, Spain.
Marta Bódalo-TorruellaMARGenomics, IMIM (Hospital del Mar Research Institute), Barcelona, Spain.
Fabiola Blasco-HernandoDepartment of Infectious Diseases, Hospital del Mar-IMIM, Barcelona, Spain.
Rosana Muñoz-BermúdezDepartment of Infectious Diseases, Hospital del Mar-IMIM, Barcelona, Spain.
Miquel ClarósMARGenomics, IMIM (Hospital del Mar Research Institute), Barcelona, Spain.
Lara NonellMARGenomics, IMIM (Hospital del Mar Research Institute), Barcelona, Spain.
Julia Perera-BelMARGenomics, IMIM (Hospital del Mar Research Institute), Barcelona, Spain.
Marta Fernandez-GonzálezDepartment of Infectious Diseases, Hospital del Mar-IMIM, Barcelona, Spain.
Xavier NoguesCentro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), IMIM (Hospital del Mar Research Institute), Barcelona, Spain.
Luisa Sorli-RedóDepartment of Infectious Diseases, Hospital del Mar-IMIM, Barcelona, Spain.
Robert Güerri-FernándezCentro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), IMIM (Hospital del Mar Research Institute), Barcelona, Spain.
Hospital Del Mar · ESMunicipal Institute for Medical Research · ESThe University of Texas Health Science Center at San Antonio · USUniversitat Pompeu Fabra · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the hallmarks of SARS-CoV-2 infection is an induced immune dysregulation, in some cases resulting in cytokine storm syndrome and acute respiratory distress syndrome (ARDS). Several physiological parameters are altered as a result of infection and cytokine storm. Among them, microRNAs (miRNAs) might reflect this poor condition since they play a significant role in immune cellular performance including inflammatory responses. Circulating miRNAs in patients who underwent ARDS and needed mechanical ventilation (MV+; n = 15) were analyzed by next generation sequencing in comparison with patients who had COVID-19 poor symptoms but without intensive care unit requirement (MV-; n = 13). A comprehensive in silico analysis by integration with public gene expression dataset and pathway enrichment was performed. Whole miRNA sequencing identified 170 differentially expressed miRNAs between patient groups. After the validation step by qPCR in an independent sample set (MV+  = 10 vs. MV- = 10), the miR-369-3p was found significantly decreased in MV+ patients (Fold change - 2.7). After integrating with gene expression results from COVID-19 patients, the most significant GO enriched pathways were acute inflammatory response, regulation of transmembrane receptor protein Ser/Thr, fat cell differentiation, and regulation of biomineralization and ossification. In conclusion, miR-369-3p was altered in patients with mechanical ventilation requirement in comparison with COVID-19 patients without this requirement. This miRNA is involved in inflammatory response which it can be considered as a prognosis factor for ARDS in COVID-19 patients.

Indexed as

Circulating MicroRNACOVID-19MicroRNAsRespiratory Distress SyndromeCytokine Release SyndromeHumansSARS-CoV-2Circulating MicroRNAMicroRNAs

Identifiers

PMID35484171
PMCPMC9047579
OpenAlexW4225010540

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.